Similar Articles
761 Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
762 Recent advances in non-invasive magnetic resonance imaging assessment of hepatocellular carcinoma
763 Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection
764 Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis
765 Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
766 Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
767 Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
768 Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
769 Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models
770 Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA